Abstract:Abstract Background Affinity chromatography is one of the most efficient protein purification strategies. This technique comprises a one-step procedure with a purification level in the order of several thousand-fold, adaptable for various proteins, differentiated in their size, shape, charge, and other properties. The aim of this work was to verify the possibility of applying affinity chromatography in bacteriophage purification, with the perspective of therapeutic purposes. T4 is a large, icosahedral phage that may serve as an efficient display platform for foreign peptides or proteins. Here we propose a new method of T4 phage purification by affinity chromatography after its modification with affinity tags (GST and Histag) by in vivo phage display. As any permanent introduction of extraneous DNA into a phage genome is strongly unfavourable for medical purposes, integration of foreign motifs with the phage genome was not applied. The phage was propagated in bacteria expressing fusions of the phage protein Hoc with affinity tags from bacterial plasmids, independently from the phage expression system. Results Elution profiles of phages modified with the specific affinity motifs (compared to non-specific phages) document their binding to the affinity resins and effective elution with standard competitive agents. Non-specific binding was also observed, but was 10 2 -10 5 times weaker than the specific one. GST-modified bacteriophages were also effectively released from glutathione Sepharose by proteolytic cleavage. The possibility of proteolytic release was designed at the stage of expression vector construction. Decrease in LPS content in phage preparations was dependent on the washing intensity; intensive washing resulted in preparations of 11-40 EU/ml. Conclusions Affinity tags can be successfully incorporated into the T4 phage capsid by the in vivo phage display technique and they strongly elevate bacteriophage affinity to a specific resin. Affinity chromatography can be considered as a new phage purification method, appropriate for further investigations and development.

Helper phage in phage antibody repertoires technology:research progress

Advances in Studies on Phage Display Systems

Generation of Antibody Libraries for Phage Display: Preparation of Helper Phage

The Progress on Phage Display Antibody Library Technology and High-Throughput Isolation of Antibodies

Progress in Phage-displayed Antibody Libraries

Advancement in the development of single chain antibodies using phage display technology

The role of phage display in therapeutic antibody discovery

Phage Display Libraries for Antibody Therapeutic Discovery and Development

Generating Recombinant Antibodies to Membrane Proteins through Phage Display

Research Advances in Application of Phage Antibody Library Technology

Developing recombinant antibodies by phage display technology to neutralize viral infectious diseases

Evolution of phage display libraries for therapeutic antibody discovery

Improving Phage Antibody Chip by Pⅷ Display System

A compact phage display human scFv library for selection of antibodies to a wide variety of antigens

Generation of Antibody Libraries for Phage Display: Library Reamplification

Phage Display Technology as a Powerful Platform for Antibody Drug Discovery

Generation of Antibody Libraries for Phage Display: Human Fab Format

A Simple Whole-Plasmid PCR Method to Construct High-Diversity Synthetic Phage Display Libraries

Construction of a large phage display antibody library by in vitro package and in vivo recombination

Purification of phage display-modified bacteriophage T4 by affinity chromatography

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy